pI: 4.8148 |
Length (AA): 450 |
MW (Da): 46720 |
Paralog Number:
4
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 450 | 1f52 (A) | 2 | 468 | 20.00 | 0 | 1 | 1.09697 | 0.83 |
15 | 444 | 4hpp (A) | 3 | 439 | 29.00 | 0 | 1 | 1.22446 | 0.22 |
104 | 256 | 4bax (A) | 88 | 248 | 33.00 | 0.0000018 | 0.33 | 0.4832 | 0.77 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase, Dormant phase. | hasan murphy |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_127086)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G53180 | nodulin/glutamine synthase-like protein |
Cryptosporidium hominis | Chro.60524 | glutamine synthetase |
Cryptosporidium parvum | cgd6_4570 | glutamate synthetase, possible bacterial origin, beta-grasp+glutamate synthase catalytic domain |
Dictyostelium discoideum | DDB_G0295755 | glutamine synthetase type I |
Dictyostelium discoideum | DDB_G0280191 | amidohydrolase 2 family protein |
Dictyostelium discoideum | DDB_G0276835 | glutamate-ammonia ligase |
Escherichia coli | b3870 | glutamine synthetase |
Escherichia coli | b1297 | glutamate--putrescine ligase |
Homo sapiens | ENSG00000146166 | lengsin, lens protein with glutamine synthetase domain |
Mycobacterium leprae | ML1631c | PROBABLE GLUTAMINE SYNTHETASE GLNA2 (GLUTAMINE SYNTHASE) (GS-II) |
Mycobacterium leprae | ML0925 | GLUTAMINE SYNTHETASE GLNA1 (GLUTAMINE SYNTHASE) (Glutamate--ammonia ligase 1) (GS-I) |
Mus musculus | ENSMUSG00000050217 | lengsin, lens protein with glutamine synthetase domain |
Mycobacterium tuberculosis | Rv1879 | Conserved hypothetical protein |
Mycobacterium tuberculosis | Rv2222c | Probable glutamine synthetase GlnA2 (glutamine synthase) (GS-II) |
Mycobacterium tuberculosis | Rv1878 | Probable glutamine synthetase GlnA3 (glutamine synthase) (GS-I) |
Mycobacterium tuberculosis | Rv2220 | Glutamine synthetase GlnA1 (glutamine synthase) (GS-I) |
Mycobacterium tuberculosis | Rv2860c | Probable glutamine synthetase GlnA4 (glutamine synthase) (GS-II) |
Mycobacterium ulcerans | MUL_2988 | hypothetical protein |
Mycobacterium ulcerans | MUL_1335 | glutamine synthetase |
Mycobacterium ulcerans | MUL_1340 | glutamine synthetase GlnA1 |
Neospora caninum | NCLIV_034160 | Glutamine synthetase (EC 6.3.1.2), related |
Oryza sativa | 4348794 | Os10g0456500 |
Plasmodium berghei | PBANKA_0823500 | glutamine synthetase, putative |
Plasmodium falciparum | PF3D7_0922600 | glutamine synthetase, putative |
Plasmodium knowlesi | PKNH_0720600 | glutamine synthetase, putative |
Plasmodium vivax | PVX_099540 | glutamine synthetase, putative |
Plasmodium yoelii | PY04688 | glutamine synthetase, putative |
Schistosoma japonicum | Sjp_0096930 | Glutamine synthetase, putative |
Schistosoma japonicum | Sjp_0318030 | expressed protein |
Schistosoma japonicum | Sjp_0217840 | ko:K01915 glutamine synthetase [EC6.3.1.2], putative |
Schistosoma mansoni | Smp_133770 | glutamine synthetase bacteria |
Schistosoma mansoni | Smp_021460 | glutamine synthetase bacteria |
Schmidtea mediterranea | mk4.012966.02 | Lengsin |
Schmidtea mediterranea | mk4.006404.02 | Lengsin |
Schmidtea mediterranea | mk4.000871.05 | Lengsin |
Schmidtea mediterranea | mk4.024807.00 | Lengsin |
Schmidtea mediterranea | mk4.006224.04 | Lengsin |
Schmidtea mediterranea | mk4.000871.04 | Lengsin |
Schmidtea mediterranea | mk4.023608.00 | Lengsin |
Toxoplasma gondii | TGME49_273490 | glutamine synthetase, type I, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0275 | glutamine synthetase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1908 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu1909 | Mycobacterium tuberculosis | non-essential | nmpdr |
b1297 | Escherichia coli | non-essential | goodall |
b3870 | Escherichia coli | non-essential | goodall |
PBANKA_0823500 | Plasmodium berghei | Dispensable | plasmo |
TGME49_273490 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mycobacterium leprae | PROBABLE GLUTAMINE SYNTHETASE GLNA2 (GLUTAMINE SYNTHASE) (GS-II) | Compounds | References |
Mycobacterium tuberculosis | Probable glutamine synthetase GlnA2 (glutamine synthase) (GS-II) | Compounds | References |
Escherichia coli | glutamine synthetase | Compounds | References |
41 literature references were collected for this gene.